Pharmaceutical Manufacturing of Furosemide Injection, USP

The contract entails the manufacture and supply of sterile, preservative-free Furosemide Injection, USP, provided in 2 mL single-dose vials at a concentration of 10 mg/mL. The production must adhere to stringent standards set by the FDA, USP, and the Defense Logistics Agency (DLA), ensuring compliance with regulatory and quality requirements. The contract is a subcontract issued by the Department of Defense through the Medical Supply Chain Pharm FSA, focusing on pharmaceutical manufacturing under NAICS code 325412. The solicitation was posted on May 28, 2026, with a response deadline of June 3, 2026. The place of performance is listed as FPO with zip code 96667, and it involves supplying the product to meet federal medical supply needs. This contract seeks qualified manufacturers capable of producing high-quality sterile injections to support defense medical logistics.